Test Price
2,800 AED✅ Home Collection Available
Multiple Myeloma Comprehensive Profile (MMCP) Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
Test: Multiple Myeloma Comprehensive Profile (MMCP)
Price: 2,800 AED
Turnaround Time: 3 Working Days
Sample Requirement: Peripheral Blood & Bone Marrow Aspirate
Collection Protocol: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
Clinical Utility: Diagnostic gold standard for multiple myeloma, plasmacytoma, and plasma cell dyscrasias. Integrates serum protein electrophoresis (SPEP), immunofixation, free light chains, quantitative immunoglobulins, complete blood count, and bone marrow flow cytometry with CD38/CD138/CD45/CD19/CD56 panel.
Test Overview & Methodology
The MMCP test integrates serum protein electrophoresis (SPEP) with immunofixation, serum free light chains, quantitative immunoglobulins, complete blood count (VCS technology), and bone marrow flow cytometry. It is the definitive panel for diagnosing, classifying, and monitoring multiple myeloma and related plasma cell disorders. All testing is performed at our CAP-accredited and ISO 9001:2015 certified laboratory facility in Dubai Healthcare City.
| Feature | Our MMCP Test | Standard SPEP Only |
|---|---|---|
| Methodology | Multi-platform: Capillary Electrophoresis, CLIA, Flow Cytometry, VCS Hematology, Immunoturbidimetry | Agarose Gel Electrophoresis only |
| Diagnostic Sensitivity | 99.9% | ~85% (limited clonality detection) |
| Bone Marrow Analysis | Included: Flow cytometry with CD38/CD138/CD45/CD19/CD56 panel | Not included |
| Turnaround Time | 3 Working Days | 5-7 Days |
| MRD Monitoring | Sensitive; suitable for minimal residual disease detection | Limited |
Physician Insight & Safety Protocols
Mr. Prabhakar Reddy Kalathoor (Specialist Diagnostic Radiology, DHA ID: 61713011) notes: "This comprehensive panel integrates peripheral blood and bone marrow findings to deliver a precise diagnosis, yet it must always be interpreted in full clinical context. Patients should never alter or stop any prescribed medication without discussing with their oncologist."
⚠️ Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. Anti-CD38 monoclonal antibody therapy (e.g., daratumumab) may interfere with immunofixation results; please inform the laboratory if you are on such treatment.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Known severe coagulopathy (INR > 2.0, platelets < 30,000/µL) – relative contraindication for bone marrow aspiration.
- Exclusion: Active uncontrolled infection at biopsy site.
- Seek immediate emergency care if you experience: sudden severe bone pain, confusion or vomiting (signs of hypercalcemia), loss of sensation in legs, or acute kidney injury symptoms.
Patient FAQ & Clinical Guidance
1. What is the Multiple Myeloma Comprehensive Profile test?
This profile combines serum electrophoresis, immunofixation, and bone marrow flow cytometry for precise myeloma detection. It measures monoclonal protein (M-protein), kappa/lambda free light chains, complete blood count, and plasma cell clonality. Physicians use it for initial workup, response assessment, and remission monitoring.
2. Why do I need a bone marrow biopsy and flow cytometry?
Bone marrow testing confirms plasma cell clonality and percentage, essential for DHA-based myeloma staging. The aspirate and core biopsy allow assessment of marrow infiltration, cytogenetics, and CD38/CD138 expression – all critical for classifying risk and selecting targeted therapy. Without bone marrow evaluation, a definitive diagnosis cannot be established per standard ICD-10-CM criteria (C90.0).
3. How is the sample collected and what support is available?
Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. Your MMCP report is delivered within 3 working days from sample collection. Our physicians will call you to explain the findings in plain language and recommend next steps. Urgent critical values are communicated immediately.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE strictly adheres to the following legal frameworks:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL): Governing the collection, processing, and storage of your personal health information.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields: Regulating the secure digital transmission of medical records and telemedicine consultations.
- Federal Decree-Law No. 4 of 2016 on Medical Liability: Ensuring clinical safety, informed consent protocols, and patient rights throughout the diagnostic process.
All test results are encrypted and accessible only to authorized healthcare providers. Direct billing coordination with your insurer is available via WhatsApp, ensuring a seamless and confidential experience.
Clinical & Logistical Metadata
| Test Name | Multiple Myeloma Comprehensive Profile (MMCP) |
| Price (AED) | 2,800 |
| Turnaround Time | 3 Working Days |
| Sample Type / Matrix | Peripheral Blood & Bone Marrow Aspirate |
| Methodology Used | Capillary Electrophoresis, CLIA, Flow Cytometry, VCS Hematology, Immunoturbidimetry |
| ICD-10-CM Code | C90.0 (Multiple Myeloma), D47.2 (Monoclonal Gammopathy) |
| LOINC Code | 80735-0 |
| DHA Facility License & Address | License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians